Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis

Journal of Neuroimmunology

Volumn 132, Issue 1-2, 2002, Pages 156-163

  Visser, Lizette ^a   De Vos, Alex F ^a   Hamann, Jörg ^b   Melief, Marie José ^a   Van Meurs, Marjan ^a   Van Lier, René A W ^b   Laman, Jon D ^a   Hintzen, Rogier Q ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adhesion; Complement; Costimulation; CSF; EGF TM7 family; Experimental autoimmune encephalomyelitis

Indexed keywords

CD97 ANTIGEN; DECAY ACCELERATING FACTOR; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CELL ACTIVATION; CELL MIGRATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMYELINATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; STAINING; T LYMPHOCYTE; WHITE MATTER;

ANTIGENS, CD; ANTIGENS, CD55; BRAIN CHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 0036850384     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00306-5     Document Type: Article

References (41)

1. Aust G., Eichler W., Laue S., Lehmann I., Heldin N.E., Lotz O., Scherbaum W.A., Dralle H., Hoang-Vu C. CD97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res. 57:1997;1798-1806.
2. Baraczka K., Nékám K., Pozsonyi T., Jakab L., Szongoth M., Seszták M. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation. 9:2001;49-54.
3. Baud V., Chissoe S.L., Viegas-Pequignot E., Diriong S., N'Guyen V.C., Roe B.A., Lipinski M. EMR1, an unusual member in the family of hormone receptors with seven transmembrane segments. Genomics. 26:1995;334-344.
4. Boulday G., Hamann J., Soulillou J.P., Charreau B. CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells. Transplantation. 73:2002;429-436.
5. Boylan M.T., Crockard A.D., McDonnell G.V., McMillan S.A., Hawkins S.A. Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis. Immunol. Lett. 78:2001;183-187.
6. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;424-435.
7. Claassen E., Gerritse K., Laman J.D., Boersma W.J. New immunoenzyme-cytochemical stainings for the in situ detection of epitope specificity and isotype of antibody forming B cells in experimental and natural (auto) immune responses in animals and man. J. Immunol. Methods. 150:1992;207-216.
8. Davis L.S., Patel S.S., Atkinson J.P., Lipsky P.E. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J. Immunol. 141:1988;2246-2252.
9. Eichler W., Aust G., Hamann D. Characterization of an early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac(F2). Scand. J. Immunol. 39:1994;111-115.
10. Gray J.X., Haino M., Roth M.J., Maguire J.E., Jensen P.N., Yarme A., Stetler-Stevenson M.A., Siebenlist U., Kelly K. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J. Immunol. 157:1996;5438-5447.
11. Hamann J., Eichler W., Hamann D., Kerstens H.M., Poddighe P.J., Hoovers J.M., Hartmann E., Strauss M., van Lier R.A. Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain. J. Immunol. 155:1995;1942-1950.
12. Hamann J., Vogel B., van Schijndel G.M., van Lier R.A. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184:1996;1185-1189.
13. Hamann J., Stortelers C., Kiss-Toth E., Vogel B., Eichler W., van Lier R.A. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Eur. J. Immunol. 28:1998;1701-1707.
14. Hamann J., Wishaupt J.O., van Lier R.A., Smeets T.J., Breedveld F.C., Tak P.P. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum. 42:1999;650-658.
15. Hintzen R.Q., van Lier R.A., Kuijpers K.C., Baars P.A., Schaasberg W., Lucas C.J., Polman C.H. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 35:1991;211-217.
16. Hintzen R.Q., Lens S.M., Beckmann M.P., Goodwin R.G., Lynch D., van Lier R.A. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J. Immunol. 152:1994;1762-1773.
17. Jaspars L.H., Vos W., Aust G., van Lier R.A., Hamann J. Tissue distribution of the human CD97 EGF-TM7 receptor. Tissue Antigens. 57:2001;325-331.
18. Kwakkenbos M.J., Chang G.-W., Lin H.-H., Pouwels W., de Jong E.C., van Lier R.A.W., Gordon S., Hamann J. The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells. J. Leukoc. Biol. 71:2002;854-862.
19. Laman J.D., van Meurs M., Schellekens M.M., de Boer M., Melchers B., Massacesi L., Lassmann H., Claassen E., Hart B.A. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J. Neuroimmunol. 86:1998;30-45.
20. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98:1999;77-88.
21. Lin H.H., Stacey M., Hamann J., Gordon S., McKnight A.J. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. Genomics. 67:2000;188-200.
22. Lin H.H., Stacey M., Saxby C., Knott V., Chaudhry Y., Evans D., Gordon S., McKnight A.J., Handford P., Lea S. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex. J. Biol. Chem. 276:2001;24160-24169.
23. Lublin D.M., Atkinson J.P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:1989;35-58.
24. Lund-Johansen F., Olweus J., Symington F.W., Arli A., Thompson J.S., Vilella R., Skubitz K., Horejsi V. Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidylinositol-anchored antigens. Eur. J. Immunol. 23:1993;2782-2791.
25. Mason J.C., Yarwood H., Sugars K., Morgan B.P., Davies K.A., Haskard D.O. Induction of decay-accelerating factor by cytokines or the membrane attack complex protects vascular endothelial cells against complement deposition. Blood. 94:1999;1673-1682.
26. McKnight A.J., Gordon S. The EGF-TM7 family: unusual structures at the leukocyte surface. J. Leukoc. Biol. 63:1998;271-280.
27. McMillan S.A., McDonnell G.V., Douglas J.P., Droogan A.G., Hawkins S.A. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis. Neurology. 51:1998;1156-1160.
28. Nechiporuk T., Urness L.D., Keating M.T. ETL, a novel seven-transmembrane receptor that is developmentally regulated in the heart. ETL is a member of the secretin family and belongs to the epidermal growth factor-seven-transmembrane subfamily. J. Biol. Chem. 276:2001;4150-4157.
29. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343:2000;938-952.
30. Ott M., Seidl C., Westhoff U., Stecker K., Seifried E., Fischer P.A., Grosse-Wilde H. Soluble HLA class I and class II antigens in patients with multiple sclerosis. Tissue Antigens. 51:1998;301-304.
31. Padberg F., Feneberg W., Schmidt S., Schwarz M.J., Korschenhausen D., Greenberg B.D., Nolde T., Muller N., Trapmann H., Konig N., Moller H.J., Hampel H. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J. Neuroimmunol. 99:1999;218-223.
32. Schrijver I.A., Melief M.J., Eulderink F., Hazenberg M.P., Laman J.D. Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells. J. Infect. Dis. 179:1999;1459-1468.
33. Shenoy-Scaria A.M., Kwong J., Fujita T., Olszowy M.W., Shaw A.S., Lublin D.M. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1. J. Immunol. 149:1992;3535-3541.
34. Shibuya K., Abe T., Fujita T. Decay-accelerating factor functions as a signal transducing molecule for human monocytes. J. Immunol. 149:1992;1758-1762.
35. Stacey M., Lin H.H., Gordon S., McKnight A.J. LNB-TM7, a group of seven-transmembrane proteins related to family-B G-protein-coupled receptors. Trends Biochem. Sci. 25:2000;284-289.
36. Stacey M., Lin H.H., Hilyard K.L., Gordon S., McKnight A.J. Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils. J. Biol. Chem. 276:2001;18863-18870.
37. Tak P.P., Hintzen R.Q., Teunissen J.J., Smeets T.J., Daha M.R., van Lier R.A., Kluin P.M., Meinders A.E., Swaak A.J., Breedveld F.C. Expression of the activation antigen CD27 in rheumatoid arthritis. Clin. Immunol. Immunopathol. 80:1996;129-138.
38. Tosello A.C., Mary F., Amiot M., Bernard A., Mary D. Activation of T cells via CD55: recruitment of early components of the CD3-TCR pathway is required for IL-2 secretion. J. Inflam. 48:1998;13-27.
39. van der Valk P., De Groot C.J. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 26:2000;2-10.
40. van Waesberghe J.H., Kamphorst W., De Groot C.J., van Walderveen M.A., Castelijns J.A., Ravid R., Lycklama a Nijeholt G.J., van der Valk P., Polman C.H., Thompson A.J., Barkhof F. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 46:1999;747-754.
41. Vedeler C.A., Matre R., Sadallah S., Schifferli J. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis. J. Neuroimmunol. 67:1996;17-20.